HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Collis Selected Research

avoralstat

9/2018Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.
12/2016Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Collis Research Topics

Disease

2Hereditary Angioedemas
09/2018 - 12/2016
1Angioedema
09/2018
1Eczema
12/2016
1Syncope (Fainting)
12/2016
1Abdominal Pain (Pain, Abdominal)
12/2016
1Back Pain (Backache)
12/2016

Drug/Important Bio-Agent (IBA)

2avoralstatIBA
09/2018 - 12/2016
2Plasma KallikreinIBA
09/2018 - 12/2016
1Kallikreins (Kallikrein)IBA
09/2018